Regenerative Medicine

Biomedical Engineering, Biological Sciences, and Animal Science


Central to preparing students for careers in regenerative medicine is a rigorous internship at a company or academic laboratory focused on Regenerative Medicine and/or Stem Cell Research. The Internship will occur over ten months (Aug 15 - June 15) at one of our partner institutions. The Internship Project(s) will be designed to allow the students to progress from supervised to independent work, with the goal of collecting results of a publishable volume and quality. The Internship will culminate with a written report and oral presentation of the Internship Project, and an evaluation by the Intern’s Supervisor. Overall, the Internship will provide trainees the opportunity to master their laboratory skills, and develop their critical thinking, problem-solving, and communication skills.  

Industry Sites

A2 Biotherapeutics

  • engineered and gene edited T-Cell therapies to treat solid tumors
  • Intern Hosts: Process Development and Technical Operations Groups

CSL Behring

  • ex vivo gene modification of hematopoeitic stem cells for treating rare diseases, such as Sickle Cell Disease, and in vitro model systems to assess gene-modified cells
  • Intern Hosts: Cell Manufacturing & Process Development, Bioanalytics, and Gene Therapy Groups

Direct Biologics

  • bone marrow mesenchymal stem cell derived extracellular vesicles to treat acute respiratory distress syndrome, including for COVID-19
  • Intern Hosts: Research & Development


  • iPSC-derived models to evaluate cardiotoxicity and neurotoxicity of investigational compounds probe mechanisms of toxicity
  • Intern Hosts: Investigative Toxicology Group in the department of Safety Assessment in Research and Early Development 

Regenerative Patch Technologies

  • tissue engineered retinal pigmented epithelium and scaffold to treat the dry form of age-related macular degeneration.
  • Intern Hosts: Research & Development

Rubedo Life Sciences

  • Pharmacological approach to induce apoptosis in senescent cells to improve stem cell function in multiple tissues to mitigate effects of chemotherapy toxicity 
  • Intern Hosts: Preclinical Research

T-Cure Bioscience

  • Identification of T-Cell Receptors (TCR) that recognize epithelial tumor antigens and preclinical characterization of leukocytes transduced with promising TCRs
  • Intern Hosts: Research & Development

ThermoFisher Scientific

  • Developing tools for iPSC generation and differentiation, and for manufacturing/quality control of clinical therapies
  • Intern Hosts: Cell Biology Group


  • Combination product comprising stem cell-derived beta cells in an immunoisolation device to treat type I diabetes
  • Intern Hosts: Product Engineering Group and Cell Engineering Group

Academic Sites

The Salk Institute

University of California, San Diego

Related Content